Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Implications for registry-based vaccine effectiveness studies from an evaluation of an immunization registry: a cross-sectional study.

Mahon BE, Shea KM, Dougherty NN, Loughlin AM.

BMC Public Health. 2008 May 14;8:160. doi: 10.1186/1471-2458-8-160.

2.

Respiratory syncytial virus immunoprophylaxis: impact on epidemiology.

Dougherty NN, Meissner HC.

Paediatr Drugs. 2000 Mar-Apr;2(2):127-32.

PMID:
10937464
4.

A further analysis of the use of cytomegalovirus immune globulin in orthotopic liver transplant patients at risk for primary infection. Boston Center for Liver Transplantation CMVIG-Study Group.

Snydman DR, Werner BG, Dougherty NN, Griffith J, Rohrer RH, Freeman R, Jenkins R, Lewis WD, O'Rourke E.

Transplant Proc. 1994 Oct;26(5 Suppl 1):23-7. No abstract available.

PMID:
7940972
5.

Cytomegalovirus immune globulin prophylaxis in liver transplantation. A randomized, double-blind, placebo-controlled trial.

Snydman DR, Werner BG, Dougherty NN, Griffith J, Rubin RH, Dienstag JL, Rohrer RH, Freeman R, Jenkins R, Lewis WD, Hammer S, O'Rourke E, Grady GF, Fawaz K, Kaplan MM, Hoffman MA, Katz AT, Doran M; Boston Center for Liver Transplantation CMVIG Study Group.

Ann Intern Med. 1993 Nov 15;119(10):984-91.

PMID:
8214995
6.

Use of ganciclovir plus cytomegalovirus immune globulin to treat CMV pneumonia in orthotopic liver transplant recipients. The Boston Center for Liver Transplantation CMVIG-Study Group.

George MJ, Snydman DR, Werner BG, Dougherty NN, Griffith J, Rohrer RH, Freeman R, Jenkins R, Lewis WD.

Transplant Proc. 1993 Oct;25(5 Suppl 4):22-4. No abstract available.

PMID:
8212303

Supplemental Content

Loading ...
Support Center